SEMAGRIX 0.25MG INJ

SEMAGRIX 0.25MG INJ contains semaglutide, a GLP-1 receptor agonist used for managing type 2 diabetes and weight management. Each injection delivers 0.25mg of the active ingredient, designed for subcutaneous administration as part of a comprehensive treatment plan. This medication helps improve blood sugar control and may support weight reduction when combined with diet and exercise. Suitable for adults requiring injectable diabetes therapy or weight management support. Always use as directed by your healthcare provider and store according to package instructions.